9.Robert C, Schachter J, Long GV, et al. Pembrolizumab versus ipilimumab in advanced melanoma.N Engl J Med.2015;372(26):2521–2532. doi:10.1056/NEJMoa1503093 Selected Indications for KEYTRUDA® (pembrolizumab) Advanced Melanoma or Adjuvant Therapy for Melanoma ...